Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in young women with PCOS are linked to higher blood pressure.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Using psychological treatments can help manage skin conditions along with regular medical care.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Combined microneedling and minoxidil improves hair growth more than minoxidil alone.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.